Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| UNITED THERAPEUTICS Corp | 42,592 | reported | 29 May 2026 | tx 6997+15,769,788−16,188,922.32 |
| BETA Technologies, Inc. | 1,071 | reported | 30 Jan 2026 | tx 1+1,071 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 29 May 2026 | EXERCISE | UNITED THERAPEUTICS Corp | 9,500 | 146.03 USD | 10b5-1 |
| 29 May 2026 | SALE | UNITED THERAPEUTICS Corp | 280 | 548.60 USD | 10b5-1 |
| 29 May 2026 | SALE | UNITED THERAPEUTICS Corp | 769 | 549.59 USD | 10b5-1 |
| 29 May 2026 | SALE | UNITED THERAPEUTICS Corp | 1,605 | 550.60 USD | 10b5-1 |
| 29 May 2026 | SALE | UNITED THERAPEUTICS Corp | 986 | 551.34 USD | 10b5-1 |
| 29 May 2026 | SALE | UNITED THERAPEUTICS Corp | 680 | 552.58 USD | 10b5-1 |
| 29 May 2026 | SALE | UNITED THERAPEUTICS Corp | 823 | 553.73 USD | 10b5-1 |
| 29 May 2026 | SALE | UNITED THERAPEUTICS Corp | 817 | 554.57 USD | 10b5-1 |
| 29 May 2026 | SALE | UNITED THERAPEUTICS Corp | 1,000 | 555.59 USD | 10b5-1 |
| 29 May 2026 | SALE | UNITED THERAPEUTICS Corp | 461 | 556.67 USD | 10b5-1 |
| 29 May 2026 | SALE | UNITED THERAPEUTICS Corp | 918 | 557.80 USD | 10b5-1 |
| 29 May 2026 | SALE | UNITED THERAPEUTICS Corp | 841 | 558.81 USD | 10b5-1 |
| 29 May 2026 | SALE | UNITED THERAPEUTICS Corp | 320 | 559.41 USD | 10b5-1 |
| 29 May 2026 | EXERCISE | UNITED THERAPEUTICS Corp | 9,500 | 0.00 USD | 10b5-1deriv |
| 28 May 2026 | SALE | UNITED THERAPEUTICS Corp | 300 | 571.55 USD | 10b5-1 |
| 28 May 2026 | EXERCISE | UNITED THERAPEUTICS Corp | 9,500 | 146.03 USD | 10b5-1 |
| 28 May 2026 | SALE | UNITED THERAPEUTICS Corp | 295 | 561.53 USD | 10b5-1 |
| 28 May 2026 | SALE | UNITED THERAPEUTICS Corp | 1,520 | 562.59 USD | 10b5-1 |
| 28 May 2026 | SALE | UNITED THERAPEUTICS Corp | 1,638 | 563.68 USD | 10b5-1 |
| 28 May 2026 | SALE | UNITED THERAPEUTICS Corp | 1,369 | 564.59 USD | 10b5-1 |
| 28 May 2026 | SALE | UNITED THERAPEUTICS Corp | 563 | 565.69 USD | 10b5-1 |
| 28 May 2026 | SALE | UNITED THERAPEUTICS Corp | 1,261 | 566.72 USD | 10b5-1 |
| 28 May 2026 | SALE | UNITED THERAPEUTICS Corp | 1,339 | 567.76 USD | 10b5-1 |
| 28 May 2026 | SALE | UNITED THERAPEUTICS Corp | 728 | 568.78 USD | 10b5-1 |
| 28 May 2026 | SALE | UNITED THERAPEUTICS Corp | 227 | 569.57 USD | 10b5-1 |
2 purchases reported after at least 12 months of silence — most recent on 26 May 2026.